ES2158360T3 - Mimeticos de rotacion en sentido inverso y metodos relacionados con ellos. - Google Patents
Mimeticos de rotacion en sentido inverso y metodos relacionados con ellos.Info
- Publication number
- ES2158360T3 ES2158360T3 ES96937733T ES96937733T ES2158360T3 ES 2158360 T3 ES2158360 T3 ES 2158360T3 ES 96937733 T ES96937733 T ES 96937733T ES 96937733 T ES96937733 T ES 96937733T ES 2158360 T3 ES2158360 T3 ES 2158360T3
- Authority
- ES
- Spain
- Prior art keywords
- reverse
- mimetics
- rotation
- methods related
- reverse sense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Toys (AREA)
- Detergent Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA INVENCION SE REFIERE A COMPUESTOS CONSTREÑIDOS CONFORMACIONALMENTE DE FORMULA (I), QUE MIMETIZAN LA ESTRUCTURA SECUNDARIA DE REGIONES DE ROTACION INVERSA DE PEPTIDOS Y PROTEINAS BIOLOGICAMENTE ACTIVOS. DICHAS SUSTANCIAS MIMETICAS DE ROTACION INVERSA SON UTILES EN UNA AMPLIA VARIEDAD DE CAMPOS, INCLUYENDO SU UTILIZACION COMO AGENTES TERAPEUTICOS Y DE DIAGNOSTICO. SE DESCRIBEN ASIMISMO BIBLIOTECAS QUE CONTIENEN DICHAS SUSTANCIAS MIMETICAS, ASI COMO METODOS DE SELECCION DE LAS MISMAS PARA IDENTIFICAR SUSTANCIAS BIOLOGICAMENTE ACTIVAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/549,007 US5929237A (en) | 1995-10-27 | 1995-10-27 | Reverse-turn mimetics and methods relating thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2158360T3 true ES2158360T3 (es) | 2001-09-01 |
Family
ID=24191284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96937733T Expired - Lifetime ES2158360T3 (es) | 1995-10-27 | 1996-10-24 | Mimeticos de rotacion en sentido inverso y metodos relacionados con ellos. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5929237A (es) |
EP (1) | EP0876371B1 (es) |
JP (1) | JPH11513986A (es) |
KR (1) | KR19990067102A (es) |
AT (1) | ATE203025T1 (es) |
AU (1) | AU719620B2 (es) |
CA (1) | CA2235138C (es) |
DE (1) | DE69613861T2 (es) |
ES (1) | ES2158360T3 (es) |
WO (1) | WO1997015577A1 (es) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6184223B1 (en) | 1995-10-27 | 2001-02-06 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
US6455047B1 (en) * | 1997-09-19 | 2002-09-24 | Serex, Inc. | Methods to improve immunogenicity of antigens and specificity of antibodies |
AU767185B2 (en) | 1998-03-23 | 2003-11-06 | President And Fellows Of Harvard College | Synthesis of compounds and libraries of compounds |
AUPP254898A0 (en) * | 1998-03-24 | 1998-04-23 | University Of Queensland, The | Peptide turn mimetics |
US6294525B1 (en) * | 1999-09-01 | 2001-09-25 | Molecumetics Ltd. | Reverse-turn mimetics and methods relating thereto |
PE20010955A1 (es) * | 1999-12-21 | 2001-10-11 | Procter & Gamble | Compuestos mimeticos de peptidos de giros beta y procesos para su fabricacion |
US6872825B2 (en) | 1999-12-21 | 2005-03-29 | The Procter & Gamble Company | Peptide β-turn mimetic compounds and processes for making them |
US8163289B2 (en) * | 2001-03-09 | 2012-04-24 | Iterative Therapeutics, Inc. | Methods and compositions involving polymeric immunoglobulin fusion proteins |
US7511121B2 (en) * | 2001-03-09 | 2009-03-31 | Arnason Barry G W | Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
US7662960B2 (en) * | 2001-04-26 | 2010-02-16 | Choongwae Pharma Corporation | Beta-strand mimetics and method relating thereto |
WO2002092010A2 (en) * | 2001-05-16 | 2002-11-21 | Molecumetics, Ltd. | Reverse-turn mimetics and methods relating thereto |
SE0102327D0 (sv) | 2001-06-28 | 2001-06-28 | Active Biotech Ab | A novel engineered superantigen for human therapy |
US6943157B2 (en) * | 2001-10-09 | 2005-09-13 | Myriad Genetics, Inc. | Reverse-turn mimetics and composition and methods relating thereto |
CA2462922C (en) * | 2001-10-12 | 2010-05-25 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
US7232822B2 (en) * | 2001-10-12 | 2007-06-19 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
US20040072831A1 (en) * | 2001-10-12 | 2004-04-15 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
US7671054B1 (en) | 2001-10-12 | 2010-03-02 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
US7566711B2 (en) * | 2001-10-12 | 2009-07-28 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
US7576084B2 (en) * | 2001-10-12 | 2009-08-18 | Choongwae Pharma Corporation | Reverse-turn mimetics and method relating thereto |
US8080657B2 (en) * | 2001-10-12 | 2011-12-20 | Choongwae Pharma Corporation | Compounds of reverse turn mimetics and the use thereof |
US7041499B2 (en) | 2001-12-12 | 2006-05-09 | University Of North Texas Health Science Center | Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
US6762185B1 (en) | 2002-03-01 | 2004-07-13 | Choongwae Pharma Corporation | Compounds useful for treatment of cancer, compositions containing the same, and methods of their use |
CA2502644A1 (en) * | 2002-10-17 | 2004-04-29 | Myriad Genetics, Inc. | Reverse-turn mimetics and composition and methods relating thereto |
AU2004268647B2 (en) | 2003-08-28 | 2010-07-01 | Choongwae Pharma Corporation | Modulation of beta-catenin/TCF activated transcription |
US20050209256A1 (en) * | 2004-03-19 | 2005-09-22 | Andres Charles J Jr | Novel beta-turn mimetics as calcitonin gene related peptide receptor antagonists |
US20050222158A1 (en) * | 2004-03-19 | 2005-10-06 | Andres Charles J Jr | Method of treating migraine headaches using calcitonin gene related peptide mimetics |
US7915251B2 (en) | 2005-03-18 | 2011-03-29 | Institute For Chemical Genomics | Alpha-helix mimetics and methods relating to the treatment of fibrosis |
ES2570994T3 (es) * | 2005-11-08 | 2016-05-23 | Choongwae Pharma Corp | Miméticos de alfa-hélice y método relacionados con el tratamiento de células madre de cáncer |
US20070179094A1 (en) | 2006-01-31 | 2007-08-02 | Bayer Schering Pharma Ag | Modulation of MDL-1 activity for treatment of inflammatory disease |
US7964181B2 (en) * | 2006-03-30 | 2011-06-21 | Palatin Technologies, Inc. | Amino acid surrogates for peptidic constructs |
US8580746B2 (en) * | 2006-03-30 | 2013-11-12 | Palatin Technologies, Inc. | Amide linkage cyclic natriuretic peptide constructs |
US8114844B2 (en) * | 2006-03-30 | 2012-02-14 | Palatin Technologies, Inc. | Linear and cyclic melanocortin receptor-specific peptidomimetics |
ATE543097T1 (de) | 2006-07-27 | 2012-02-15 | Univ Maryland | Zellulärer rezeptor für antiproliferativen faktor |
US8450481B2 (en) * | 2007-06-14 | 2013-05-28 | The Regents Of The University Of California | Compounds for inhibiting protein aggregation, and methods for making and using them |
JP2009040696A (ja) * | 2007-08-07 | 2009-02-26 | Kikkoman Corp | 新規アンジオテンシン変換酵素阻害ペプチド |
KR101588736B1 (ko) | 2008-01-10 | 2016-01-26 | 리서치 디벨롭먼트 파운데이션 | 얼리키아 샤피엔시스에 대한 백신 및 진단제 |
US8008291B2 (en) | 2008-02-29 | 2011-08-30 | Mimetica Pty Ltd | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists |
US8343958B2 (en) | 2008-02-29 | 2013-01-01 | Mimetica Pty Ltd | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists |
US8377925B2 (en) | 2008-02-29 | 2013-02-19 | Mimetica Pty Ltd | Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor |
US8455488B2 (en) | 2008-06-06 | 2013-06-04 | Prism Biolab Corporation | Alpha helix mimetics and methods relating thereto |
WO2010033220A2 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Modified therapeutics peptides, methods of their preparation and use |
EP2334335A1 (en) * | 2008-09-19 | 2011-06-22 | Nektar Therapeutics | Polymer conjugates of cd-np peptides |
EP2337585A1 (en) * | 2008-09-19 | 2011-06-29 | Nektar Therapeutics | Polymer conjugates of glp-2-like peptides |
EP2334336A1 (en) * | 2008-09-19 | 2011-06-22 | Nektar Therapeutics | Polymer conjugates of osteocalcin peptides |
EP2350118B1 (en) * | 2008-09-19 | 2016-03-30 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
EP2334337A1 (en) * | 2008-09-19 | 2011-06-22 | Nektar Therapeutics | Polymer conjugates of opioid growth factor peptides |
WO2010033204A2 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of c-peptides |
WO2010033215A2 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of aod-like peptides |
WO2010033227A1 (en) * | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of thymosin alpha 1 peptides |
EP2340047A1 (en) * | 2008-09-19 | 2011-07-06 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
JP5545573B2 (ja) | 2008-10-14 | 2014-07-09 | 株式会社 PRISM BioLab | アルファへリックスミメティック及び関連の方法 |
PL2352508T3 (pl) | 2008-10-17 | 2014-09-30 | Dana Farber Cancer Inst Inc | Peptydy domeny cytoplazmatycznej MUC-1 jako inhibitory nowotworu |
WO2010120112A2 (en) * | 2009-04-15 | 2010-10-21 | Choongwae Pharma Corporation | Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof |
WO2010129347A2 (en) | 2009-04-28 | 2010-11-11 | Vanderbilt University | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
JP5768239B2 (ja) | 2009-05-07 | 2015-08-26 | 株式会社 PRISM BioLab | アルファへリックスミメティック及び関連の方法 |
CN102906566A (zh) | 2010-02-03 | 2013-01-30 | 株式会社棱镜生物实验室 | 与天然变性蛋白质结合的化合物及其筛选方法 |
WO2011115819A2 (en) | 2010-03-15 | 2011-09-22 | Genus Oncology, Llc | Small molecule inhibitors of muc1 and methods of identifying the same |
TWI531573B (zh) | 2010-10-14 | 2016-05-01 | Jw製藥公司 | 新穎反轉模擬物之化合物及其用途 |
US20140051706A1 (en) | 2011-02-25 | 2014-02-20 | Prism Pharma Co., Ltd. | Alpha helix mimetics and methods relating thereto |
US9140698B2 (en) | 2011-04-06 | 2015-09-22 | The Board Of Regents Of The University Of Texas System | Modulating bacterial MAM polypeptides in pathogenic disease |
US20150072933A1 (en) | 2011-08-01 | 2015-03-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Novel sequences for the control of reproduction in fish |
WO2013026015A1 (en) | 2011-08-18 | 2013-02-21 | Dana-Farber Cancer Institute, Inc. | Muc1 ligand traps for use in treating cancers |
WO2014045126A2 (en) | 2012-09-18 | 2014-03-27 | Uti Limited Partnership | Treatment of pain by inhibition of usp5 de-ubiquitinase |
US9789156B2 (en) | 2013-03-11 | 2017-10-17 | Dana-Farber Cancer Institute, Inc. | Combination anti-human epidermal growth factor receptor 2 (anti-HER2) cancer therapy using mucin 1 (MUC1) peptides and hemotherapeutics |
WO2014164395A1 (en) | 2013-03-11 | 2014-10-09 | Dana-Farber Cancer Institute, Inc. | Combination anti-estrogen receptor cancer therapy using muc1 peptides and chemotherapeutics |
MY193211A (en) | 2013-03-15 | 2022-09-26 | Bayer Healthcare Llc | Gla domains as targeting agents |
CN105899211A (zh) | 2013-10-18 | 2016-08-24 | 小路弘行 | 使用cbp/连环蛋白的抑制剂治疗肝纤维化 |
US9963498B2 (en) | 2016-08-18 | 2018-05-08 | Wisconsin Alumni Research Foundation | Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R |
AU2018330427A1 (en) | 2017-09-05 | 2020-04-02 | GLAdiator Biosciences, Inc. | Method of targeting exosomes |
WO2022092294A1 (ja) | 2020-10-30 | 2022-05-05 | 学校法人慶應義塾 | サルコペニア関連疾患等の新規治療および予防 |
WO2023089556A1 (en) | 2021-11-22 | 2023-05-25 | Pfizer Inc. | Reducing risk of antigen mimicry in immunogenic medicaments |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0573608A1 (en) * | 1991-02-07 | 1993-12-15 | Molecumetics, Ltd. | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
WO1994003494A1 (en) * | 1992-08-06 | 1994-02-17 | The Board Of Trustees Of The University Of Illinois | Conformationally restricted mimetics of reverse turns and peptides containing the same |
US5288514A (en) * | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US5886186A (en) * | 1995-10-25 | 1999-03-23 | Versicor, Inc. | Synthesis of substituted N-heteroaromatic compounds and methods of use thereof |
-
1995
- 1995-10-27 US US08/549,007 patent/US5929237A/en not_active Expired - Lifetime
-
1996
- 1996-10-24 AU AU75205/96A patent/AU719620B2/en not_active Ceased
- 1996-10-24 EP EP96937733A patent/EP0876371B1/en not_active Expired - Lifetime
- 1996-10-24 JP JP9516777A patent/JPH11513986A/ja active Pending
- 1996-10-24 KR KR1019980703042A patent/KR19990067102A/ko not_active Application Discontinuation
- 1996-10-24 WO PCT/US1996/017053 patent/WO1997015577A1/en not_active Application Discontinuation
- 1996-10-24 ES ES96937733T patent/ES2158360T3/es not_active Expired - Lifetime
- 1996-10-24 AT AT96937733T patent/ATE203025T1/de not_active IP Right Cessation
- 1996-10-24 CA CA002235138A patent/CA2235138C/en not_active Expired - Fee Related
- 1996-10-24 DE DE69613861T patent/DE69613861T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH11513986A (ja) | 1999-11-30 |
CA2235138C (en) | 2005-04-05 |
EP0876371A1 (en) | 1998-11-11 |
AU7520596A (en) | 1997-05-15 |
DE69613861D1 (de) | 2001-08-16 |
CA2235138A1 (en) | 1997-05-01 |
KR19990067102A (ko) | 1999-08-16 |
AU719620B2 (en) | 2000-05-11 |
ATE203025T1 (de) | 2001-07-15 |
WO1997015577A1 (en) | 1997-05-01 |
US5929237A (en) | 1999-07-27 |
EP0876371B1 (en) | 2001-07-11 |
DE69613861T2 (de) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2158360T3 (es) | Mimeticos de rotacion en sentido inverso y metodos relacionados con ellos. | |
CA2286733A1 (en) | Reverse-turn mimetics and methods relating thereto | |
ATE301656T1 (de) | Reverse-turnmimetika und damit zusammenhängendes verfahren | |
DK0836485T3 (da) | Kaskade-polymer-komplekser, fremgangsmåde til deres fremstilling og farmaceutiske midler indeholdende disse | |
BRPI0409124A (pt) | miméticos de direção inversa e método relacionado aos mesmos | |
DE69635653D1 (de) | Peptide als vektoren zur intrazellulären adressierung von aktiven molekülen | |
BRPI0509888A (pt) | miméticos de direção inversa e método relacionado aos mesmos | |
ATE370734T1 (de) | Reverse-turn mimetika als alpha 4ss integrin blocker | |
TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
DE69938786D1 (de) | Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe | |
FR2766193B1 (fr) | Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique | |
DE69520475T2 (de) | Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen | |
BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
DK403384A (da) | Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf | |
DE69434777D1 (de) | Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln | |
FR2764508B1 (fr) | Nouveaux vecteurs liposomaux de principes actifs | |
ATE242202T1 (de) | Peptide | |
IT8948430A0 (it) | Composti tripeptidici e loro uso farmaceutico come immuno-modulatori | |
NO980296L (no) | Forbedrede terapeutiske midler | |
NO20000519L (no) | 2-acylaminopropanaminer som takykininreseptorantagonister | |
FR2732978B1 (fr) | Vecteur viral recombinant, composition pharmaceutique le contenant et cellules transformees correspondantes | |
DK0614910T3 (da) | Renset form af streptograminer, dens fremstilling og farmaceutiske præparater indeholdende denne form | |
EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
BRPI0318325B8 (pt) | compostos miméticos de beta-fita | |
DE69326145T2 (de) | Synthetische peptide für die behandlung von myasthenia gravis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 876371 Country of ref document: ES |